|
Science in Sport PLC on Monday said its loss narrowed during 2024 as it eyes the recently-agreed takeover by bd-capital Partners Ltd. The London-based sports nutrition company said pretax loss narrowed to £4.7 million in 2024 from £11.3 million in 2023. Revenue, however, declined 17% to £51.9 million from £62.7 million. This reflected the company’s reset of its business operating model ‘in a performance of which the board is proud but has proved challenging given the level of turnaround required’, it said. Cost of sales declined 21% to £28.4 million from £35.8 million, while administrative expenses fell 26% to £27.1 million from £36.6 million. Science in Sport in mid-April agreed the terms for a takeover by bd-capital, valuing the company at 34 pence per share. Shareholders are advised to vote in favour of the acquisition at its upcoming annual general meeting. Shares in Science in Sport closed down 0.8% at 32.75 pence in London on Monday. The stock has more than doubled from 15.75p over the past year. ‘Management is taking an ambitious yet balanced view on prospects for 2025 where trading performance has started well with the improvements made throughout 2024 continuing to annualise,’ said Chair Dan Wright. ‘The strategic focus areas are driving profitable revenue growth through distribution agreements both domestically and internationally; controlled growth over the medium term supported by effective marketing with a clear strong commercial execution; and, continued margin improvements from ongoing cost challenge resulting in cash generation and deleveraging. ‘Whilst these improvements have started to be realised maximising the group’s full potential is likely to require further capital investment in distribution and product range to scale quickly as significant growth of marginally accretive revenue requires a longer-term outlook.’ Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
